AU2003277663A1 - Screening method - Google Patents

Screening method

Info

Publication number: AU2003277663A1
Authority: AU; Australia
Prior art keywords: screening method; screening
Prior art date: 2002-11-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003277663A

Inventor

Ryo Fujii

Shuji Hinuma

Fumio Itoh

Yuji Kawamata

Hidetoshi Komatsu

Hiroshi Uejima

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takeda Pharmaceutical Co Ltd

Original Assignee

Takeda Chemical Industries Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-12

Filing date

2003-11-11

Publication date

2004-06-03

2003-11-11 Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd

2004-06-03 Publication of AU2003277663A1 publication Critical patent/AU2003277663A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Transplantation (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)

AU2003277663A 2002-11-12 2003-11-11 Screening method Abandoned AU2003277663A1 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
JP2002328581		2002-11-12
JP2002-328581		2002-11-12
JP2003-092033		2003-03-28
JP2003092033		2003-03-28
JP2003-168817		2003-06-13
JP2003168817		2003-06-13
PCT/JP2003/014292 WO2004043468A1 (en)	2002-11-12	2003-11-11	Screening method

Publications (1)

Publication Number	Publication Date
AU2003277663A1 true AU2003277663A1 (en)	2004-06-03

Family

ID=32314785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003277663A Abandoned AU2003277663A1 (en)	2002-11-12	2003-11-11	Screening method

Country Status (2)

Country	Link
AU (1)	AU2003277663A1 (en)
WO (1)	WO2004043468A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004067008A1 (en)	2003-01-28	2004-08-12	Takeda Pharmaceutical Company Limited	Receptor agonists
JPWO2006070718A1 (en) *	2004-12-27	2008-06-12	萬有製薬株式会社	Drugs for diseases associated with increase or decrease in total bile acid pool amount or lipid metabolic diseases, and screening methods for these drugs
JPWO2010016552A1 (en)	2008-08-07	2012-01-26	武田薬品工業株式会社	Drugs for irritable bowel syndrome
WO2013102929A1 (en)	2011-12-26	2013-07-11	Cadila Healthcare Limited	Novel compounds for treatment of diabetes, obesity or related disorders
WO2014100021A1 (en)	2012-12-17	2014-06-26	Exelixis, Inc.	Tgr5 agonists: imidazole and triazole compounds containing a quaternary nitrogen
CN102993103B (en) *	2012-12-25	2015-07-29	湖南科技大学	N1, N3-dialkyl group replaces 3,4-dihydro-pyrimidin-2 ketone derivatives and preparation method thereof
WO2015016682A1 (en)	2013-08-01	2015-02-05	경희대학교 산학협력단	Pharmaceutical composition for preventing or treating diabetes mellitus, method for preventing or treating diabetes mellitus, and method for screening for diabetes mellitus therapeutic agent
KR101688639B1 (en)	2013-08-01	2016-12-21	경희대학교 산학협력단	Composition for preventing or treating diabetes mellitus, method for preventing or treating diabetes mellitus, and method for screening antidiabetics
US10077241B2 (en)	2014-04-15	2018-09-18	Jansen Pharmaceutica Nv	Tetrahydro-benzoimidazolyl modulators of TGR5
EP3174872A1 (en) *	2014-07-29	2017-06-07	Université de Lille 2 Droit et Santé	2-oxo-3,4-dihydropyridine-5-carboxylates and their use
WO2017134188A1 (en) *	2016-02-03	2017-08-10	Universite De Lille 2 Droit Et Sante	Novel dihydropyridinone and dihydropyrimidinone compounds and their use
KR102568042B1 (en) *	2018-09-25	2023-08-21	이창 휴먼웰 파마슈티칼 코포레이션, 리미티드	Modulators of TGR5 Signaling as Immunomodulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002040669A1 (en) *	2000-11-17	2002-05-23	Banyu Pharmaceutical Co., Ltd.	Novel guanosine triphosphate (gtp) binding protein-coupled receptor protein, bg37
WO2002072823A2 (en) *	2001-02-20	2002-09-19	Bayer Aktiengesellschaft	Human g protein-coupled receptor
US7354726B2 (en) *	2001-04-12	2008-04-08	Takeda Pharmaceutical Company Limited	Screening method

2003
- 2003-11-11 WO PCT/JP2003/014292 patent/WO2004043468A1/en not_active Ceased
- 2003-11-11 AU AU2003277663A patent/AU2003277663A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2004043468A1 (en)	2004-05-27

Publication	Publication Date	Title
AU2003296064A1 (en)	2004-07-29	Circular-cylinder sieve
AU2003258070A1 (en)	2004-02-23	Electrodionization method
AU2003277663A1 (en)	2004-06-03	Screening method
AU2002249467A1 (en)	2002-11-18	Screening method
AU2003242340A1 (en)	2003-12-31	Novel screening method
AU2003902613A0 (en)	2003-06-12	Self-surveying method
AU2003227268A1 (en)	2003-10-13	Novel screening method
AU2003285503A1 (en)	2005-06-24	Screening method
AU2003253813A1 (en)	2004-01-23	Method for colpoplasty
AU2003264722A1 (en)	2004-03-11	Methods
AU2003242342A1 (en)	2004-02-02	Novel screening method
AU2002952966A0 (en)	2002-12-12	Screening apparatus
AU2003202622A1 (en)	2003-09-04	A method of screening
AU2003217008A1 (en)	2003-09-29	Screening method
AU2002354247A1 (en)	2003-06-30	Screening method
AU2003278535A1 (en)	2004-01-06	Histoscreen method
AU2003248955A1 (en)	2004-02-09	Screening method
AU2003235310A1 (en)	2003-11-03	Novel screening method
AU2003303311A1 (en)	2004-08-30	Methods for selecting and screening for trasformants
AU2003210099A1 (en)	2003-09-16	New method
AUPS286102A0 (en)	2002-06-27	Screening method
AU2003235120A1 (en)	2003-11-10	Screening method
AU2002952433A0 (en)	2002-11-21	Screening method
AU2003280725A1 (en)	2004-06-03	Screening method
AU2002308887A1 (en)	2003-07-24	Regional bioimpedancemetry method

Legal Events

Date	Code	Title	Description
2005-07-28	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase